September 3, 2008 -- Sandoz has received US Food and Drug Administration approval for its Omnitrope® Pen 10 with liquid cartridge. Omnitrope, a somatropin, is approved for long-term treatment of pediatric patients who have growth failure and long-term replacement therapy in adults with growth hormone deficiency.
The details can be read here.
No comments:
Post a Comment